Doctor Takeshi Yamashita
Cardiovascular Institute, Tokyo (Japan)
Impact of polypharmacy on clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry
Event: ESC Congress 2021 - The Digital Experience
Topic: Stroke in Atrial Fibrillation
Session: Atrial fibrillation e-posters
Real-world effectiveness and the safety of anticoagulant treatment in elderly non-valvular atrial fibrillation in the ANAFIE registry, the largest real-world elderly AF registry
Event: ESC Congress 2020
Topic: Stroke in Atrial Fibrillation
Session: Oral Anticoagulant Therapy in the Elderly with Atrial Fibrillation
Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program
Event: ESC Congress 2020
Topic: Oral Anticoagulation
Session: Oral Anticoagulant Therapy in the Elderly with Atrial Fibrillation
Real-world effectiveness and the safety of anticoagulant treatment in elderly non-valvular atrial fibrillation in the ANAFIE registry, the largest real-world elderly AF registry
Event: ESC Asia with APSC & AFC 2020
Topic: Stroke in Atrial Fibrillation
Session: Abstract Programme
Edoxaban treatment of elderly patients with atrial fibrillation in routine clinical practice: 1-year results of the non-interventional Global ETNA-AF program
Event: ESC Asia with APSC & AFC 2020
Topic: Oral Anticoagulation
Session: Abstract Programme
ESC 365 is supported by
